Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-06, Stock:PFE, The news for the past five days is as follows:
2019-02-27: NEWS1: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS2: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS3: Big Pharma&apos;s Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS4: IUSG, PFE, USB, ISRG: ETF Inflow Alert.NEWS5: IUSG, PFE, USB, ISRG: ETF Inflow Alert.NEWS6: The patent system ‘keeps American drug prices so high’.NEWS7: Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 28, 2019.NEWS8: Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 28, 2019.NEWS9: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 28, 2019.NEWS10: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 28, 2019.
2019-02-28: NEWS1: Top technician says charts point to healthy gains ahead for this stock.NEWS2: After Hours Most Active for Feb 28, 2019 :  CSCO, ZTO, ABEV, CMCSA, AAPL, MSFT, ATVI, BAC, VALE, KKR, SBUX, PFE.NEWS3: After Hours Most Active for Feb 28, 2019 :  CSCO, ZTO, ABEV, CMCSA, AAPL, MSFT, ATVI, BAC, VALE, KKR, SBUX, PFE.NEWS4: Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript.NEWS5: Dow Movers: DWDP, PFE.NEWS6: Dow Movers: DWDP, PFE.NEWS7: Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older.
2019-03-01: NEWS1: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS2: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS3: After Hours Most Active for Mar 1, 2019 :  ABEV, GE, XOM, PFE, AR, TSM, SGMS, AAPL, SHY, MSFT, MCHI, INTC.NEWS4: After Hours Most Active for Mar 1, 2019 :  ABEV, GE, XOM, PFE, AR, TSM, SGMS, AAPL, SHY, MSFT, MCHI, INTC.NEWS5: Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended.NEWS6: Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended.NEWS7: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS8: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS9: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS10: Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended.NEWS11: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS12: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS13: Nektar Therapeutics (NKTR) Q4 2018 Earnings Conference Call Transcript.NEWS14: Pfizer Receives Positive CHMP Opinion for LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer.NEWS15: Pfizer unit Meridian under civil investigation by U.S. Attorney.NEWS16: ICU Medical Inc (ICUI) Q4 2018 Earnings Conference Call Transcript.
2019-03-04: NEWS1: This Biotech Stock Just Flew To A Record After Topping Pfizer In A Study.NEWS2: Here's Why Ascendis Pharma Is Rocketing Higher Today.NEWS3: Here's Why Ascendis Pharma Is Rocketing Higher Today.NEWS4: Here&apos;s Why Ascendis Pharma Is Rocketing Higher Today.NEWS5: Can This Biotech Puppy Run With the Big Dogs?.NEWS6: Can This Biotech Puppy Run With the Big Dogs?.NEWS7: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS8: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS9: Pfizer or Mylan: Who Is Expected to Report Faster EPS Growth?.NEWS10: Pfizer Inc. -- Moody's assigns A1 rating to Pfizer's notes; stable outlook.NEWS11: Pfizer and Mylan: What to Expect from Revenue Growth in 2019.NEWS12: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS13: Can This Biotech Puppy Run With the Big Dogs?.NEWS14: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for March 05, 2019.NEWS15: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for March 05, 2019.NEWS16: Why Sangamo Therapeutics Lost 22.9% of Its Value in February.NEWS17: Why Sangamo Therapeutics Lost 22.9% of Its Value in February.NEWS18: What Analysts Recommend for Pfizer and Mylan in March.NEWS19: Market Trends Toward New Normal in Pfizer, Hyatt Hotels, Wipro, Garmin, Ameren, and Qorvo — Emerging Consolidated Expectations, Analyst Ratings.NEWS20: BioXcel Therapeutics Announces Addition of Merck KGaA, Darmstadt, Germany, and Pfizer to Clinical Collaboration with Nektar for Development of Triple-combination Therapy in Pancreatic Cancer.
2019-03-05: NEWS1: Lilly to Bring Half-Priced Version of Popular Humalog Insulin.NEWS2: Pfizer and Mylan: How Capex, Interest Expenses, and Debt Stack Up.NEWS3: AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes.NEWS4: Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference.NEWS5: Health Care Sector Update for 03/05/2019: ADMS, NNVC, NVTA, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Health Care Sector Update for 03/05/2019: ADMS, NNVC, NVTA, JNJ, PFE, MRK, ABT, AMGN.NEWS7: Comparing Dividends and Free Cash Flow for Pfizer and Mylan.NEWS8: Lilly to Bring Half-Priced Version of Popular Humalog Insulin.NEWS9: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS10: Pfizer or Mylan: Who Is Controlling Expenses Better?.NEWS11: The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings.NEWS12: [$$] Scott Gottlieb to step down as head of FDA.NEWS13: Pfizer Prices $5,000,000,000 Debt Offering.

Answer: Decrease